» Articles » PMID: 33462899

Short- and Long-term Prognostic Value of Right Ventricular Function in Patients with First Acute ST Elevation Myocardial Infarction Treated by Primary Angioplasty

Overview
Date 2021 Jan 19
PMID 33462899
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Limited data are known about the prognostic value of right ventricle (RV) function in patients with first acute ST-segment elevation myocardial infarction (STEMI). The aim of this study was to investigate the prognostic value of RV dysfunction in predicting both in-hospital and long-term outcomes in these patients, irrespective of the site of necrosis.

Methods: We enrolled 502 consecutive patients with first acute STEMI treated with primary angioplasty and underwent echocardiography within 48 hours of admission. RV function was evaluated by RV myocardial performance index (RVMPI), RV fractional area change (RVFAC), tricuspid annular plane systolic excursion (TAPSE), pulsed tissue Doppler S' wave velocity, and RV global longitudinal strain (RVGLS) of the free wall. The occurrence of in-hospital major adverse cardiac events (MACE) and 1-year survival rate were recorded.

Results: In MACE group, RVFAC, TAPSE, and RV S' wave velocity were lower. However, RVMPI, RVGLS, and TR Vmax. were higher than MACE free group (P < .001). In multivariable analysis adjusted for other variables that predicted adverse outcomes, RVFAC < 35% (P < .001), TAPSE < 17 mm (P < .001), RVGLS > -17% (P < .001), RV S' wave velocity < 9.5 cm/s (P = .02), RVMPI > 0.43 (P < .001), and TR Vmax. > 2.8 m/s (P = .01) were strong independent predictors of in-hospital MACE. Lower 1-year survival was noted in patients with RV dysfunction, documented by these cutoffs values.

Conclusion: RV dysfunction, evidenced by multiparametric echocardiography, is predictive for adverse in-hospital outcomes, and lower 1-year survival rate in first acute STEMI regardless of the site of necrosis.

Citing Articles

Prognostic Implications of Clinical, Laboratory and Echocardiographic Biomarkers in Patients with Acute Myocardial Infarction-Rationale and Design of the ''CLEAR-AMI Study''.

Daios S, Anastasiou V, Moysidis D, Didagelos M, Papazoglou A, Stalikas N J Clin Med. 2023; 12(17).

PMID: 37685793 PMC: 10488329. DOI: 10.3390/jcm12175726.


Prognostic Value of Systemic Immune-Inflammation Index and NT-proBNP in Patients with Acute ST-Elevation Myocardial Infarction.

Zhu Y, He H, Qiu H, Shen G, Wang Z, Li W Clin Interv Aging. 2023; 18:397-407.

PMID: 36959838 PMC: 10029373. DOI: 10.2147/CIA.S397614.


Predictive value of myocardial strain on myocardial infarction size by cardiac magnetic resonance imaging in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction.

Wang Q, Wang J, Ma Y, Wang P, Li Y, Tian J Front Pharmacol. 2022; 13:1015390.

PMID: 36313364 PMC: 9613930. DOI: 10.3389/fphar.2022.1015390.


The Prognostic Importance of Right Ventricular Longitudinal Strain in Patients with Cardiomyopathies, Connective Tissue Diseases, Coronary Artery Disease, and Congenital Heart Diseases.

Tadic M, Kersten J, Nita N, Schneider L, Buckert D, Gonska B Diagnostics (Basel). 2021; 11(6).

PMID: 34073460 PMC: 8228710. DOI: 10.3390/diagnostics11060954.